Wayne W. Grody

Wayne W. Grody's AcademicInfluence.com Rankings

Wayne W. Grody

Philosophy

#8357

World Rank

#11716

Historical Rank

Logic

#5390

World Rank

#6784

Historical Rank

philosophy Degrees

Wayne W. Grody

Biology

#11300

World Rank

#14686

Historical Rank

Pathology

#152

World Rank

#276

Historical Rank

Genetics

#1219

World Rank

#1320

Historical Rank

Biochemistry

#1857

World Rank

#1997

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Wayne W. Grody Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Wayne W. Grody's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (2015) (15496)
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing (2013) (2235)
Clinical exome sequencing for genetic identification of rare Mendelian disorders. (2014) (848)
DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study (2011) (847)
ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 (2008) (741)
Comparative properties of arginases. (1996) (594)
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study (2012) (521)
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening (2001) (421)
Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel (2004) (409)
College of American Pathologists' laboratory standards for next-generation sequencing clinical tests. (2015) (308)
Activation, transformation, and subunit structure of steroid hormone receptors. (1982) (283)
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. (2017) (260)
Arginases I and II: do their functions overlap? (2004) (231)
Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. (2014) (216)
Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. (2008) (213)
ACMG position statement on prenatal/preconception expanded carrier screening (2013) (211)
Infection of the heart by the human immunodeficiency virus. (1990) (205)
Cloning and characterization of the human type II arginase gene. (1996) (179)
American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing (2001) (175)
Mouse Model for Human Arginase Deficiency (2002) (168)
Exploring concordance and discordance for return of incidental findings from clinical sequencing (2012) (163)
The human arginases and arginase deficiency (1998) (152)
Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. (2012) (143)
Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis. (1999) (139)
Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. (1991) (138)
Assessing the necessity of confirmatory testing for exome sequencing results in a clinical molecular diagnostic laboratory (2014) (130)
Quality control in molecular genetic testing (2001) (122)
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. (2017) (121)
Standards and Guidelines for CFTR Mutation Testing (2002) (114)
Thymus involution in the acquired immunodeficiency syndrome. (1985) (114)
Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations. (1997) (113)
Arginine Metabolism by Macrophages Promotes Cardiac and Muscle Fibrosis in mdx Muscular Dystrophy (2010) (111)
Studies on the structure and function of the chicken progesterone receptor. (1981) (105)
De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. (2015) (102)
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. (2017) (94)
Cloning and characterization of human agmatinase. (2002) (89)
Minimal or No Cancer in Radical Prostatectomy Specimens: Report of 13 Cases of the “Vanishing Cancer Phenomenon” (1995) (88)
Widespread Expression of Arginase I in Mouse Tissues: Biochemical and Physiological Implications (2003) (85)
Expression of arginase isozymes in mouse brain (2001) (84)
DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies (2015) (82)
Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing (2012) (80)
Benchmarks for cystic fibrosis carrier screening: a European consensus document. (2010) (78)
Technical Standards and Guidelines: Molecular Genetic Testing for Ultra-Rare Disorders (2005) (75)
Isolation of human liver arginase cDNA and demonstration of nonhomology between the two human arginase genes. (1986) (71)
The gene for human liver arginase (ARG1) is assigned to chromosome band 6q23. (1986) (68)
Molecular Biomarkers for the Evaluation of Colorectal Cancer (2017) (68)
Expression of the liver form of arginase in erythrocytes. (2002) (65)
Ornithine deficiency in the arginase double knockout mouse. (2006) (64)
An electrochemical detection scheme for identification of single nucleotide polymorphisms using hairpin-forming probes. (2002) (59)
Recommended policies for uses of human tissue in research, education, and quality control. Ad Hoc Committee on Stored Tissue, College of American Pathologists. (2009) (59)
A de novo deletion in FMR1 in a patient with developmental delay. (1994) (57)
Mature T-Cell and NK-Cell Neoplasms (2008) (57)
Gastrointestinal lymphomas: Immunohistochemical studies on the cell of origin (1985) (56)
Contrasting features of urea cycle disorders in human patients and knockout mouse models. (2008) (56)
Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears. (1996) (55)
Developing a Sustainable Process to Provide Quality Control Materials for Genetic Testing (2005) (53)
Tumor necrosis factor-alpha plays a central role in interleukin-2-induced pulmonary vascular leak and lymphocyte accumulation. (1994) (53)
De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing (2014) (52)
Differential expression of the two human arginase genes in hyperargininemia. Enzymatic, pathologic, and molecular analysis. (1989) (52)
Technical standards and guidelines: Venous thromboembolism (Factor V Leiden and prothrombin 20210G>A testing): A disease-specific supplement to the standards and guidelines for clinical genetics laboratories (2005) (51)
In situ viral DNA hybridization in diagnostic surgical pathology. (1987) (51)
The Cystic Fibrosis mutation “arms race”: when less is more (2007) (50)
International perspectives on the implementation of reproductive carrier screening (2019) (50)
Human arginase isozymes. (1987) (49)
PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population. (1997) (47)
Diagnosis and management of familial Mediterranean fever: Integrating medical genetics in a dedicated interdisciplinary clinic (2011) (47)
Should We Be Applying Warfarin Pharmacogenetics to Clinical Practice? No, Not Now (2009) (47)
Expression of arginase II in prostate cancer. (2008) (45)
Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics. (2013) (45)
Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme (1993) (43)
A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders (2020) (42)
The Clinical Significance of Circulating Tumor Cells in the Peripheral Blood (2006) (42)
Inactivation of chick oviduct progesterone receptors. (1980) (41)
Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy. (2012) (40)
Deaf adults' reasons for genetic testing depend on cultural affiliation: results from a prospective, longitudinal genetic counseling and testing study. (2010) (40)
Cystic fibrosis population carrier screening: Here at last—Are we ready? (2001) (40)
Cystic fibrosis: low frequency of DF508 mutation in 2 population samples from Rio de Janeiro, Brazil. (1999) (40)
Molecular techniques. (2018) (39)
Cloning and characterization of the mouse and rat type II arginase genes. (1998) (38)
American College of Medical Genetics STANDARDS AND GUIDELINES FOR CLINICAL GENETICS LABORATORIES (2011) (38)
Whole-Exome/Genome Sequencing and Genomics (2013) (37)
Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia. (2008) (37)
Detection of cytomegalovirus DNA in classic and epidemic Kaposi's sarcoma by in situ hybridization. (1988) (37)
Loss of function mutations in conserved regions of the human arginase I gene. (1996) (36)
Missense-depleted regions in population exomes implicate ras superfamily nucleotide-binding protein alteration in patients with brain malformation (2016) (36)
Cystic fibrosis: molecular diagnosis, population screening, and public policy. (1999) (35)
Friedreich's ataxia GAA repeat expansion in patients with recessive or sporadic ataxia (1997) (35)
Molecular pathology, informed consent, and the paraffin block. (1995) (34)
Molecular genetic risk screening. (2003) (34)
Identification of mutations (D128G, H141L) in the liver arginase gene of patients with hyperargininemia (1994) (33)
Cytomegalovirus and Rasmussen's encephalitis (1991) (32)
Emergence of pediatric rare diseases (2013) (32)
Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation. (2012) (32)
A prospective, longitudinal study of the impact of GJB2/GJB6 genetic testing on the beliefs and attitudes of parents of deaf and hard‐of‐hearing infants (2009) (32)
AAV-based Gene Therapy Prevents Neuropathology and Results in Normal Cognitive Development in the Hyperargininemic Mouse (2013) (32)
Where to Draw the Boundaries for Prenatal Carrier Screening. (2016) (32)
Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia (2009) (31)
Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector. (2009) (30)
Monitoring standards for molecular genetic testing in the United Kingdom, the Netherlands, and Ireland. (2006) (30)
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. (2017) (30)
Prenatal screening for cystic fibrosis: past, present and future (2004) (30)
Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse. (2013) (30)
Diversity of cystic fibrosis mutation-screening practices. (1998) (30)
CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG) (2020) (28)
Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. (1997) (28)
Molecular genetic study of human arginase deficiency. (1992) (28)
Arginase expression in mouse embryonic development (2002) (28)
Infant hearing loss and connexin testing in a diverse population (2008) (27)
Attitudes toward genetic carrier screening for cystic fibrosis among pregnant women: the role of health beliefs and avoidant coping style. (1997) (27)
In-frame deletions of BRCA1 may define critical functional domains (2000) (27)
Ethical issues raised by genetic testing with oligonucleotide microarrays (2003) (27)
Ethnic Differences in Parental Perceptions of Genetic Testing for Deaf Infants (2008) (26)
AIDS and the heart: Review and consideration of pathogenetic mechanisms. (1992) (26)
Detection of human immunodeficiency virus (HIV) infection in formalin-fixed, paraffin-embedded tissues by DNA amplification. (1988) (26)
Ependymoma-like tumor of the mesovarium. (1985) (25)
Microelectronic array system for molecular diagnostic genotyping: Nanogen NanoChip® 400 and Molecular Biology Workstation (2006) (24)
Cystic fibrosis carrier screening: Issues in implementation (2002) (23)
Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice. (2014) (23)
Identification of novel PIEZO1 variants using prenatal exome sequencing and correlation to ultrasound and autopsy findings of recurrent hydrops fetalis (2018) (23)
Estimated analytic validity of HFE C282Y mutation testing in population screening: The potential value of confirmatory testing (2003) (23)
A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics. (2005) (22)
Testing and reporting ACMG cystic fibrosis mutation panel results. (2007) (22)
Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization (2013) (22)
CORRIGENDUM: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing (2017) (22)
Polyamine homeostasis in arginase knockout mice. (2007) (22)
Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation (2004) (21)
Cystic Fibrosis Mutations in Costa Rica (2003) (21)
Menstrual cycle and gonadal steroid effects on symptomatic hyperammonaemia of urea-cycle-based and idiopathic aetiologies (1994) (21)
Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology (2017) (20)
Varicella-zoster DNA in temporal bones of patients with ramsay hunt syndrome (1993) (20)
Diagnostic molecular pathology. (1989) (20)
Hematopathology: Morphology, Immunophenotype, Cytogenetics, and Molecular Approaches (2008) (19)
Erratum: Standards and guidelines for CFTR mutation testing (Genetics in Medicine (2002) 4 (379-391)) (2002) (19)
Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function (2014) (19)
Electric Field-Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment. (2018) (19)
Molecular genetic testing for familial Mediterranean fever. (2000) (18)
Alternative approaches to proficiency testing in molecular genetics. (2003) (18)
Variable penetrance and expressivity of the splice altering 5T sequence in the cystic fibrosis gene. (2007) (17)
Expanded carrier screening and the law of unintended consequences: From cystic fibrosis to fragile X (2011) (17)
Is it time to retire fragile X testing as a first-tier test for developmental delay, intellectual disability, and autism spectrum disorder? (2017) (16)
Adult‐onset cyclic neutropenia responsive to cyclosporine therapy in a patient with ankylosing spondylitis (1993) (15)
Deaf Genetic Testing and Psychological Well-Being in Deaf Adults (2013) (15)
Excellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma. (2000) (14)
Report card on molecular genetic testing: room for improvement? (1999) (14)
The Case for Laboratory Developed Procedures (2017) (14)
Informativeness of VNTR genetic markers for detecting chimerism after bone marrow transplantation. (1989) (13)
Quest for controls in molecular genetics. (2003) (13)
Demonstration of cytoplasmic tyrosinase mRNA in tissue-cultured cells by reverse transcription (RT) in situ polymerase chain reaction (PCR) and RT PCR in situ hybridization. (1997) (12)
Technical Standards and Guidelines for CFTR Mutation Testing (2017) (11)
Stuck between a scalpel and a rock, or molecular pathology and legal-ethical issues in use of tissues for clinical care and research: what must a pathologist know? (2012) (11)
Development and integration of molecular genetic tests into clinical practice: the US experience (2004) (11)
Pathologic evaluation of thymic hyperplasia in myasthenia gravis and Lambert-Eaton myasthenic syndrome. (1986) (11)
Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening (2004) (11)
Acute Myeloid Leukemias with Recurrent Genetic Abnormalities (2013) (11)
The Glut of Academic Publishing: A Call for a New Culture (2010) (10)
New quality assurance standards for rare disease testing (2008) (10)
Human variome project country nodes: Documenting genetic information within a country (2012) (10)
Rapid diagnosis of Legionella infection by a nonisotopic in situ hybridization method. (1991) (10)
Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing. (2009) (10)
Colchicine's other indication--effect of FDA action. (2010) (10)
Sharing GJB2/GJB6 Genetic Test Information with Family Members (2007) (10)
Ethical ramifications of genetic analysis using DNA arrays. (2001) (9)
Privacy and data management in the era of massively parallel next-generation sequencing (2011) (9)
The transformation of medical genetics by clinical genomics: hubris meets humility (2019) (9)
Diagnostic Applications of Recombinant Nucleic Acid Technology: Neoplastic Disease (1992) (9)
Application of in situ DNA hybridization technology to diagnostic surgical pathology. (1987) (9)
Genetic testing and the early hearing detection and intervention process (2001) (9)
Gene-environment regulatory circuits of right ventricular pathology in tetralogy of fallot (2019) (9)
The Value of T-Cell Receptor γ (TRG) Clonality Evaluation by Next-Generation Sequencing in Clinical Hematolymphoid Tissues (2018) (8)
Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines. (2007) (8)
Primary central nervous system gamma delta cytotoxic T-cell lymphoma (2016) (8)
Response to Biesecker and Harrison (2018) (8)
Electric Field Induced Release and Measurement (EFIRM): Characterization and Technical Validation of a Novel Liquid Biopsy Platform in Plasma and Saliva. (2020) (8)
Offering Prenatal Screening in the Age of Genomic Medicine: A Practical Guide. (2017) (7)
Mitoxantrone/ifosfamide/etoposide salvage regimen with rituximab for in vivo purging in patients with relapsed lymphoma. (2002) (7)
Diagnostic Applications of Recombinant Nucleic Acid Technology: Basic Techniques (1991) (7)
Confidential genetic testing and electronic health records: A survey of current practices among Huntington disease testing centers (2019) (7)
The Fate of Newborn Screening Blood Spots (2010) (7)
Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results (1999) (6)
A PvuII RFLP for the human liver arginase (ARG1) gene. (1986) (6)
Proficiency testing in diagnostic molecular pathology. (1994) (6)
Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG). (2021) (6)
Effect of an adjacent base on detection of a point mutation by restriction enzyme digestion (1991) (6)
The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care (6)
Coupling clinical exome sequencing with functional characterization studies to diagnose a patient with familial Mediterranean fever and MED13L haploinsufficiency syndromes (2017) (6)
Adult T-Cell Leukemia/Lymphoma (2013) (6)
Contemporary Cancer Research (2005) (5)
Cystic fibrosis testing comes of age. (2009) (5)
Cystic Fibrosis Mutation Analysis: How Many Is Enough? (2004) (5)
An exon 1 deletion in OTC identified using chromosomal microarray analysis in a mother and her two affected deceased newborns: implications for the prenatal diagnosis of ornithine transcarbamylase deficiency. (2010) (5)
Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference (1999) (5)
Home use of a compact, 12‑lead ECG recording system for newborns. (2019) (5)
Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing (2019) (5)
A case of mycosis fungoides transmitted from donor to recipient, and review of literature of T-cell malignancies after transplantation. (2014) (4)
Genetic characterization and long-term management of severely affected siblings with intellectual developmental disorder with cardiac arrhythmia syndrome (2020) (4)
Development and Characterization of Reference Materials for MTHFR , SERPINA 1 , RET , BRCA 1 , and BRCA 2 Genetic Testing (2010) (4)
48 – Mycosis Fungoides and Sézary Syndrome (2013) (3)
The Value of T-Cell Receptor &ggr; (TRG) Clonality Evaluation by Next-Generation Sequencing in Clinical Hematolymphoid Tissues: A Descriptive Study of 41 Cases From a Single Institution (2018) (3)
Instability of a dinucleotide repeat in the 3′‐untranslated region (UTR) of the microsomal prostaglandin E synthase‐1 (mPGES‐1) gene in microsatellite instability‐high (MSI‐H) colorectal carcinoma (2015) (3)
Generalized Cytokine Increase in the Setting of a Multisystem Clinical Disorder and Carcinoid Syndrome Associated with a Novel NLRP12 Variant (2019) (3)
The coming era of cancer genetic screening. (1994) (3)
An infant with MLH3 variants, FOXG1‐duplication and multiple, benign cranial and spinal tumors: A clinical exome sequencing study (2016) (3)
Next-generation Sequencing in Clinical Molecular Diagnostics (2011) (3)
Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests (2005) (3)
Diagnostic molecular genetics: current applications and future technologies. (1997) (3)
Molecular pathology and cancer genetic screening. (1995) (3)
Education and testing strategy for large-scale cystic fibrosis carrier screening (1994) (3)
Those elusive molecular diagnostics CPT codes. (1997) (3)
Genetic linkage group (ARG1-D6S33-MYB) on chromosome 6q containing the arginase-1 and MYB genes. (1990) (2)
In situ regulation of pulmonary macrophage TNF-alpha mRNA expression by IL2. (1993) (2)
The next generation of cancer management@@@The next generation of cancer management (2016) (2)
MULTIPLEX MUTATION GENOTYPING FOR HUMAN DISEASES : BREAST CANCER AND FAMILIAL MEDITERRANEAN FEVER (2014) (2)
Molecular Diagnosis, Population Screening, and Public Policy (1999) (2)
The next generation of cancer management (2016) (2)
Role of Cytomegalovirus Infection in Acquired Immunodeficiency Syndrome, with Emphasis on Neurological and Ophthalmological Complications (1993) (2)
Functional and molecular analysis of liver arginase promoter sequences from man andMacaca fascicularis (1994) (2)
Diagnostic Molecular Genetics (2019) (2)
Discordant pursuit asymmetry and esotropia in monozygous twins. (2002) (2)
The structure and function of the progesterone receptor (1981) (2)
Pitfalls of restriction endonuclease digestion for direct detection of point mutations. (1992) (2)
Response to Biesecker et al. (2021) (2)
Update on informed consent for stored tissue research. (1996) (2)
Fixed and Embedded Samples 5 Screening for Pathogenic DNA Sequences in Clinically Collected Human Tissues (1994) (2)
The Neoplasms of Precursor Lymphoblasts (2008) (2)
Mature B-Cell Neoplasms (2008) (2)
Direct-to-consumer genotyping: are we ready for a brave new world? (2010) (2)
Multiplex SNP analysis: Screening factor V R506Q (Leiden) mutations (2003) (2)
PCR-based cystic fibrosis (CF) carrier screening in a first-year medical student biochemistry laboratory. (1993) (2)
Central 22q11.2 deletion (LCR22 B‐D) in a fetus with severe fetal growth restriction and a mother with severe systemic lupus erythematosus: Further evidence of CRKL haploinsufficiency in the pathogenesis of 22q11.2 deletion syndrome (2021) (2)
Addendum: American College of Medical Genetics consensus statement on factor V Leiden mutation testing (2021) (1)
Technical validation of the electric field-induced release and measurement (EFIRM) assay for the detection of EGFR mutations in circulating cell free DNA in plasma and saliva. (2018) (1)
DMP News and Comment (1994) (1)
Molecular basis for tissue specific expression of liver arginase (1987) (1)
Anaplastic Large Cell Lymphomas (2013) (1)
17 – Acute Myeloid Leukemia—Overview (2013) (1)
Principles of Molecular Techniques (2008) (1)
New quality assurance standards for rare disease (2008) (1)
The Stored Tissue Issue: Biomedical Research, Ethics, and Law in the Era of Genomic Medicine.ByRobert F Weirand, Robert S Olick;with, Jeffrey C Murray.Oxford and New York: Oxford University Press. $46.50. xvii + 339 p; ill.; index. ISBN: 0–19–512368–9. 2004. (2005) (1)
Molecular Diagnosis of Cystic Fibrosis (2016) (1)
Non-neoplastic and Borderline Lymphocytic Disorders (2008) (1)
Chronic Myeloproliferative Diseases (2008) (1)
In Situ Regulation of Pulmonary Macrophage TNF-α mRNA Expression by IL2 (1993) (1)
Erratum: Technical standards and guidelines: Molecular genetic testing for ultra-rare disorders (Genetics in Medicine (2005) 8, (571-583)) (2006) (1)
Next-Generation Sequencing in Molecular Diagnostics (2010) (1)
Absence of delta antigen in a series of needle biopsies of chronic active hepatitis. (1985) (1)
Recessive ciliopathy mutations in primary endocardial fibroelastosis: a rare neonatal cardiomyopathy in a case of Alstrom syndrome (2021) (1)
Genetics in Hollywood: from real to reel * (2010) (1)
Molecular genetics. Introduction. (1993) (1)
The Changing Role of the Pathologist in the Management of the Cancer Patient (2004) (1)
Molecular Pathology 1994 (1995) (1)
Plasma Cell Myeloma and Related Disorders (2008) (1)
Technology in Search of an Application (2009) (1)
Prenatal Carrier Screening-Reply. (2016) (1)
The UCLA experience in developing protocols for informed consent (2000) (1)
General Considerations in the Use and Application of Laboratory Tests for the Evaluation of Cancer (2004) (1)
Detection of bcl-2/IgH Rearrangements by Quantitative-competitive PCR and Capillary Electrophoresis (2001) (1)
A Sodium Channel Myotonia Presenting with Intermittent Dysphagia as a Manifestation of a Rare SCN4A Variant (2017) (1)
Gene-environment regulation of chamber-specific maturation during hypoxemic perinatal circulatory transition (2020) (0)
6 – Reactive Lymphadenopathies (2013) (0)
Prelingual siblings of children with GJB2 hearing loss: issues to consider. (2005) (0)
Commentary Quest for Controls in Molecular Genetics (2003) (0)
Response to Metcalfe and Archibald (2012) (0)
Eleventh International Chromosome Conference (2004) (0)
First Comprehensive Guideline Released for Molecular Biomarker Testing in Patients With Colorectal Cancer (2017) (0)
Gene expression pattern Arginase expression in mouse embryonic development (2002) (0)
Genetic biochemical disorders (1987) (0)
Gene-environment regulation of chamber-specific maturation during hypoxemic perinatal circulatory transition (2020) (0)
13 – Chronic Neutrophilic and Chronic Eosinophilic Leukemias (2013) (0)
Carrier screening: a tutorial (2005) (0)
Current Massively Parallel Sequencing Technologies: Platforms and Reporting Considerations (2018) (0)
Cytomegalovirus DNA as a Potential Placental Marker for Fetal Infection (1993) (0)
Response to Biesecker and Harrison (2018) (0)
ONLINE MEDICAL GENETICS IN PRACTICE Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR (2004) (0)
Evidence-Based Pathology and Laboratory Medicine in the Molecular Pathology Era: Transition of Tests from the Research Bench into Practice (2011) (0)
Decreased arginase II expression in androgen-independent prostate cancer cell lines. (2006) (0)
Molecular pathology 1995. Birth of an association [meeting report]. (1996) (0)
Chapter 18 – Hodgkin Lymphoma (2008) (0)
Pathology: immunohistology and in situ hybridization in the diagnosis of hepatitis B. (1986) (0)
Book Review Handbook of Gene Level Diagnostics in Clinical Practice By Victor A. Bernstam. 695 pp. Boca Raton, Fla., CRC Press, 1992. $99.50. 0-8493-6824-3 (1993) (0)
Molecular Pathology: Role in Improving Patient Outcome (2009) (0)
Reviewer Acknowledgment (2013) (0)
Pathology: in situ hybridization in diagnostic pathology. (1986) (0)
Molecular pathology: role in improving patient outcome: Overview. (1999) (0)
S2464 Misnomer Leading to Delayed Diagnosis of an Autoinflammatory Syndrome in a Latino Male (2022) (0)
Functional and molecular analysis of liver arginase promoter sequences from man and Macaca fascicularis. (1994) (0)
Lipodystrophy, NAFLD and Pancreatic Neuroendocrine Tumor in a Patient with LIPE Mutation (2017) (0)
Contents continued (2020) (0)
Lymphoid Malignancies of Non-precursor Cells (2008) (0)
Exome Sequencing Improves Clinical Diagnosis of Sporadic or Familial Cerebellar Ataxia (S32.003) (2015) (0)
Breast and prostate cancer, 1994. (1994) (0)
Integrated Genomics Analysis Identifies Recessive Ciliopathy Mutations in Primary Endocardial Fibroelastosis: a Rare Neonatal Cardiomyopathy (2021) (0)
Title A Sodium Channel Myotonia Presenting with Intermittent Dysphagia as a Manifestation of a Rare SCN 4 A Variant Permalink (2017) (0)
Differential Expression of the Two HumanArginase Genes in Hyperargininemia Enzymatic , Pathologic , and Molecular Analysis (2013) (0)
A Sodium Channel Myotonia Presenting with Intermittent Dysphagia as a Manifestation of a Rare SCN4A Variant (2016) (0)
Reversible dissociation of chick oviduct progesterone receptor subunits. (1986) (0)
1 – Structure and Function of Hematopoietic Tissues (2013) (0)
Bone Marrow Aplasia (2008) (0)
Prenatal Diagnosis of Cystic Fibrosis (2015) (0)
Chapter 8 – Myelodysplastic Syndromes (2008) (0)
Memories of Gene Herbek, MD. (2020) (0)
Informed Consent for Human Genetics Research (2000) (0)
Quality Assurance of Molecular Assays (2009) (0)
Pathology patterns : molecular pathology and molecular diagnostics (1999) (0)
Molecular Testing: Regulatory Issues (2013) (0)
In This Issue (2012) (0)
Molecular Genetic Testing and Management of Familial Mediterranean Fever (2009) (0)
The Future of Genomic Medicine (2020) (0)
Linkage Disequilibrium Analysis in a Recently Founded Population : Evaluation of the Variegate Porphyria Founder in South African Afrikaners (2007) (0)
Diagnostics: Current and Future (2005) (0)
Arginase: A Novel Proliferative Determinant in Prostate Cancer (2005) (0)
140-P: Bone marrow transplantation chimerism study on the Beckman Vidiera™ NsD, ABI 377 and ABI 3130XL electrophoresis platforms (2006) (0)
Sa1051: UTILIZATION OF A MULTIDISCIPLINARY TELEHEALTH MODEL TO IMPROVE ACCESS TO CARE AND MAINTAIN AN ACADEMIC TEACHING PARADIGM FOR A UNIQUE PATIENT POPULATION DURING THE COVID-19 PANDEMIC (2022) (0)
The transformation of medical genetics by clinical genomics: hubris meets humility (2019) (0)
Rare loss of function variants in candidate genes and risk of colorectal cancer (2018) (0)
Regulatory Issues in Molecular Diagnostics (2010) (0)
Ordering genetic tests and interpreting the results. (2011) (0)
List of Contributors (2019) (0)
Molecular testing guidelines for selection of colorectal cancer patients for targeted and conventional therapies. (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Wayne W. Grody?

Wayne W. Grody is affiliated with the following schools:

University of California, Los Angeles

Wayne W. Grody's Academic­Influence.com Rankings

Why Is Wayne W. Grody Influential?

Wayne W. Grody's Published Works

Published Works

What Schools Are Affiliated With Wayne W. Grody?

Wayne W. Grody's AcademicInfluence.com Rankings